OTCMKTS:BNKL

Bionik Laboratories (BNKL) Stock Forecast, Price & News

$0.24

0.00 (0.00%)

(As of 09/28/2023 ET)

Compare

Today's Range: $0.24
▼
$0.24
50-Day Range: $0.24
▼
$0.50
52-Week Range: $0.24
▼
$2.90

Volume: N/A
Average Volume: 147 shs
Market Capitalization: $3.00 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Financials Headlines SEC Filings Short Interest

About Bionik Laboratories (OTCMKTS:BNKL) Stock

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

BNKL Price History

30 days | 90 days | 365 days | Advanced Chart

BNKL Stock News Headlines

September 15, 2023 | msn.com

Bionik receives US patent for new rehabilitation technology

September 14, 2023 | technews.tmcnet.com

Bionik Laboratories Granted United States Patent for Innovative Rehabilitation Technology

September 29, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

June 24, 2023 | finance.yahoo.com

AI Technology Brings Innovation To Treating Stroke Patients

June 15, 2023 | finance.yahoo.com

Bionik Laboratories Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations

May 23, 2023 | finance.yahoo.com

Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida

May 4, 2023 | finance.yahoo.com

Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong

March 23, 2023 | finance.yahoo.com

Bionik Laboratories’ InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)

September 29, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

February 10, 2023 | investing.com

Zenotech Laboratories Ltd (ZENL)

February 10, 2023 | investing.com

Caplin Point Laboratories Ltd (CAPL)

February 8, 2023 | finance.yahoo.com

Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results

January 23, 2023 | nbcnews.com

After baby formula problems, Abbott Laboratories under DOJ investigation

January 23, 2023 | cnbc.com

Abbott Laboratories reportedly faces U.S. criminal probe over baby formula shortage

January 18, 2023 | marketwatch.com

Bionic Limbs Market Share From 2023 To 2028 And Unlimited Opportunities for New Companies and Latest Developments

November 9, 2022 | finance.yahoo.com

Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results

November 7, 2022 | finance.yahoo.com

Bionik Laboratories to Present at the Q4 Virtual Investor Summit

October 13, 2022 | seekingalpha.com

Bionik laboratories appoints new CEO and CFO

October 13, 2022 | finance.yahoo.com

Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer

September 8, 2022 | finance.yahoo.com

Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout

September 1, 2022 | finance.yahoo.com

BIONIK Laboratories to Present at National Investment Banking Association Conference

August 17, 2022 | investing.com

Bionik Laboratories Corp (BNKL)

August 10, 2022 | finance.yahoo.com

BIONIK Laboratories Reports First Quarter Financial Results

August 9, 2022 | tmcnet.com

BIONIK Laboratories Corp. to Present at Investor Summit Group's Q3 Virtual Conference

August 9, 2022 | finance.yahoo.com

BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference

June 23, 2022 | finance.yahoo.com

BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center

June 9, 2022 | finance.yahoo.com

BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results

See More Headlines

Receive BNKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BNKL Company Calendar

Today: 9/29/2023
Next Earnings (Estimated): 11/07/2023
Fiscal Year End: 3/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BNKL
CUSIP: N/A
CIK: 1508381
Web: www.bioniklabs.com
Phone: (617) 926-4800
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.71)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,950,000.00
Net Margins: -273.96%
Pretax Margin: -274.02%
Return on Equity: -459.32%
Return on Assets: -108.36%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.20
Quick Ratio: 0.76

Sales & Book Value

Annual Sales: $1.80 million
Price / Sales: 1.66
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.24) per share
Price / Book: -1.00

Miscellaneous

Outstanding Shares: 12,480,000
Free Float: 8,148,000
Market Cap: $3.00 million
Optionable: Not Optionable
Beta: -1.27

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Richard Paul Russo Jr. (Age 42)
CPA, CEO, Pres & Director
Comp: $298.6k

Mr. Michal Prywata (Age 32)
Co-Founder & Director
Comp: $585.87k

Mr. Daniel Gonsalves CPA (Age 39)
Exec. VP & CFO

Mr. John Smathers
Director of Operations

Key Competitors

View All Competitors

BNKL Stock - Frequently Asked Questions

How have BNKL shares performed in 2023?: Bionik Laboratories' stock was trading at $0.6225 at the beginning of 2023. Since then, BNKL shares have decreased by 61.4% and is now trading at $0.24.
View the best growth stocks for 2023 here.
When is Bionik Laboratories' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our BNKL earnings forecast.
What other stocks do shareholders of Bionik Laboratories own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bionik Laboratories investors own include Co-Diagnostics (CODX), iBio (IBIO), Revvity (PKI), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX) and Digital Ally (DGLY).
What is Bionik Laboratories' stock symbol?: Bionik Laboratories trades on the OTCMKTS under the ticker symbol "BNKL."

How do I buy shares of Bionik Laboratories?: Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Bionik Laboratories' stock price today?: One share of BNKL stock can currently be purchased for approximately $0.24.
How much money does Bionik Laboratories make?: Bionik Laboratories (OTCMKTS:BNKL) has a market capitalization of $3.00 million and generates $1.80 million in revenue each year. The company earns $-4,950,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis.
How can I contact Bionik Laboratories?: Bionik Laboratories' mailing address is 483 Bay Street N105, Toronto A6, M5G2C9. The official website for the company is www.bioniklabs.com. The company can be reached via phone at (617) 926-4800 or via email at lm@bioniklabs.com.

This page (OTCMKTS:BNKL) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial